Aryl pyridine as aldosterone synthase inhibitors

Details for Australian Patent Application No. 2010247414 (hide)

Owner Novartis AG

Inventors Chamoin, Sylvie; Hu, Qi-Ying; Papillon, Julien

Agent Davies Collison Cave

Pub. Number AU-A-2010247414

PCT Pub. Number WO2010/130796

Priority 61/318,413 29.03.10 US; 61/178,677 15.05.09 US

Filing date 12 May 2010

Wipo publication date 18 November 2010

International Classifications

C07D 213/76 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

1 December 2011 PCT application entered the National Phase

  PCT publication WO2010/130796 Priority application(s): WO2010/130796

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010247415-Method for filling food containers

2010247412-5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or CYP11B1